FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319826057> ?p ?o ?g. }

• W4319826057 endingPage "413" @default.
• W4319826057 startingPage "404" @default.
• W4319826057 abstract "Background: The aim of this multicenter observational real-world study was to investigate glycemic outcomes in children and adolescents with type 1 diabetes over the first 6-month use of MiniMed™ 780G. The secondary objective was to evaluate demographic and clinical factors that may be significantly associated with the achievement of therapeutic goals. Methods: Demographic, anamnestic, and clinical data of study participants were collected at the time of enrollment. Data on ambulatory glucose profile were acquired at 3 and 6 months after activating automatic mode. Aggregated glucose metrics and device settings of the entire study period were analyzed to identify predictors of optimal glycemic control, assessed by the concomitant achievement of time in range (TIR) >70%, coefficient of variation (CV) <36%, glucose management indicator (GMI) <7%, and time below range (TBR) <4%. Results: Our study cohort consisted of 111 children and adolescents (54.1% female) aged 7-18 years. All the most relevant clinical targets were achieved according to recommendations from the International Consensus both at 3 and 6 months. When considering aggregated data, primary goals in terms of TIR, CV, GMI, and TBR were achieved, respectively, by 72.1%, 74.8%, 68.5%, and 74.8% of participants. In addition, 44 individuals (39.6%) concomitantly addressed all the above clinical targets. Regression analysis revealed that older age, briefer duration of disease, and shorter active insulin time were significant predictors of optimal glucose control. Comparing two groups of individuals stratified according to the glycated hemoglobin (HbA1c) mean value in the year preceding MiniMed 780G use, achieving glycemic targets was observed in the subgroup with lower HbA1c. Conclusions: Our study highlights the effectiveness and safety of MiniMed 780G in the pediatric population. More extensive and personalized training on advanced hybrid closed-loop use should be considered for younger people and those with long disease duration." @default.
• W4319826057 created "2023-02-11" @default.
• W4319826057 creator A5027649273 @default.
• W4319826057 creator A5029715847 @default.
• W4319826057 creator A5034234671 @default.
• W4319826057 creator A5035904217 @default.
• W4319826057 creator A5047480463 @default.
• W4319826057 creator A5049869747 @default.
• W4319826057 creator A5050653274 @default.
• W4319826057 creator A5054183156 @default.
• W4319826057 creator A5057334553 @default.
• W4319826057 creator A5058145644 @default.
• W4319826057 creator A5074342073 @default.
• W4319826057 creator A5078416288 @default.
• W4319826057 creator A5080239986 @default.
• W4319826057 creator A5083747022 @default.
• W4319826057 date "2023-06-01" @default.
• W4319826057 modified "2023-09-22" @default.
• W4319826057 title "MiniMed 780G Six-Month Use in Children and Adolescents with Type 1 Diabetes: Clinical Targets and Predictors of Optimal Glucose Control" @default.
• W4319826057 cites W2113764001 @default.
• W4319826057 cites W2139279363 @default.
• W4319826057 cites W2165779683 @default.
• W4319826057 cites W2200741680 @default.
• W4319826057 cites W2228278621 @default.
• W4319826057 cites W2313499206 @default.
• W4319826057 cites W2399476645 @default.
• W4319826057 cites W2810372328 @default.
• W4319826057 cites W2886078506 @default.
• W4319826057 cites W2889348059 @default.
• W4319826057 cites W2916505164 @default.
• W4319826057 cites W2947026969 @default.
• W4319826057 cites W2948261890 @default.
• W4319826057 cites W2948677447 @default.
• W4319826057 cites W3046281507 @default.
• W4319826057 cites W3098183377 @default.
• W4319826057 cites W3128903399 @default.
• W4319826057 cites W3129111678 @default.
• W4319826057 cites W3172660767 @default.
• W4319826057 cites W3199839796 @default.
• W4319826057 cites W3201039184 @default.
• W4319826057 cites W3210094726 @default.
• W4319826057 cites W4200041231 @default.
• W4319826057 cites W4205778417 @default.
• W4319826057 cites W4206940098 @default.
• W4319826057 cites W4221045506 @default.
• W4319826057 cites W4221078578 @default.
• W4319826057 cites W4221135864 @default.
• W4319826057 cites W4223439323 @default.
• W4319826057 cites W4281628561 @default.
• W4319826057 cites W4283837006 @default.
• W4319826057 cites W4289595170 @default.
• W4319826057 cites W4292315862 @default.
• W4319826057 cites W4293679034 @default.
• W4319826057 cites W4294783598 @default.
• W4319826057 cites W4307776086 @default.
• W4319826057 cites W4311177574 @default.
• W4319826057 doi "https://doi.org/10.1089/dia.2022.0491" @default.
• W4319826057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36763343" @default.
• W4319826057 hasPublicationYear "2023" @default.
• W4319826057 type Work @default.
• W4319826057 citedByCount "6" @default.
• W4319826057 countsByYear W43198260572023 @default.
• W4319826057 crossrefType "journal-article" @default.
• W4319826057 hasAuthorship W4319826057A5027649273 @default.
• W4319826057 hasAuthorship W4319826057A5029715847 @default.
• W4319826057 hasAuthorship W4319826057A5034234671 @default.
• W4319826057 hasAuthorship W4319826057A5035904217 @default.
• W4319826057 hasAuthorship W4319826057A5047480463 @default.
• W4319826057 hasAuthorship W4319826057A5049869747 @default.
• W4319826057 hasAuthorship W4319826057A5050653274 @default.
• W4319826057 hasAuthorship W4319826057A5054183156 @default.
• W4319826057 hasAuthorship W4319826057A5057334553 @default.
• W4319826057 hasAuthorship W4319826057A5058145644 @default.
• W4319826057 hasAuthorship W4319826057A5074342073 @default.
• W4319826057 hasAuthorship W4319826057A5078416288 @default.
• W4319826057 hasAuthorship W4319826057A5080239986 @default.
• W4319826057 hasAuthorship W4319826057A5083747022 @default.
• W4319826057 hasConcept C126322002 @default.
• W4319826057 hasConcept C134018914 @default.
• W4319826057 hasConcept C1862650 @default.
• W4319826057 hasConcept C187212893 @default.
• W4319826057 hasConcept C201903717 @default.
• W4319826057 hasConcept C23131810 @default.
• W4319826057 hasConcept C2777180221 @default.
• W4319826057 hasConcept C2777538456 @default.
• W4319826057 hasConcept C2779306644 @default.
• W4319826057 hasConcept C2779384505 @default.
• W4319826057 hasConcept C2780473172 @default.
• W4319826057 hasConcept C35785553 @default.
• W4319826057 hasConcept C555293320 @default.
• W4319826057 hasConcept C71924100 @default.
• W4319826057 hasConcept C72563966 @default.
• W4319826057 hasConceptScore W4319826057C126322002 @default.
• W4319826057 hasConceptScore W4319826057C134018914 @default.
• W4319826057 hasConceptScore W4319826057C1862650 @default.
• W4319826057 hasConceptScore W4319826057C187212893 @default.
• W4319826057 hasConceptScore W4319826057C201903717 @default.
• W4319826057 hasConceptScore W4319826057C23131810 @default.

• next